A detailed history of Guggenheim Capital LLC transactions in Ginkgo Bioworks Hldgs Inc Wt E stock. As of the latest transaction made, Guggenheim Capital LLC holds 399,600 shares of DNAWS stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
399,600
Previous 399,600 -0.0%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
N/A
-39,560,400 Reduced 99.0%
399,600 $0
Q2 2023

Aug 11, 2023

BUY
N/A
39,560,400 Added 9900.0%
39,960,000 $0
Q1 2023

May 10, 2023

BUY
N/A
7,198 Added 1.83%
399,600 $0
Q4 2022

Feb 14, 2023

SELL
N/A
-4,869,298 Reduced 92.54%
392,402 $0
Q3 2022

Nov 14, 2022

SELL
N/A
-34,748,700 Reduced 86.85%
5,261,700 $0
Q2 2022

Aug 15, 2022

BUY
N/A
39,609,148 Added 9871.39%
40,010,400 $0
Q3 2021

Nov 15, 2021

BUY
N/A
401,252 New
401,252 $1.36 Million

Others Institutions Holding DNAWS

About GINKGO BIOWORKS HLDGS INC WT E


  • Ticker DNAWS
More about DNAWS
Track This Portfolio

Track Guggenheim Capital LLC Portfolio

Follow Guggenheim Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.